{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Neonatal cholestasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_ursodeoxycholic_acid",
          "name": "Ursodeoxycholic Acid"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_s_adenosylmethionine",
          "name": "S-adenosylmethionine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_obeticholic_acid",
          "name": "Obeticholic Acid"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rifampicin",
          "name": "Rifampicin"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_n_acetylcysteine",
          "name": "N-acetylcysteine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_silibinin",
          "name": "Silibinin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_l_carnitine",
          "name": "L-carnitine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_vitamina_e",
          "name": "Vitamina E"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTargetX",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathwayY",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdversePhenotypeZ",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_ursodeoxycholic_acid",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的旁靶作用"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险路径关联"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将影响净获益"
        }
      ],
      "merge": [
        {
          "keep": "n_rp",
          "remove": "n_rp_dup",
          "rationale": "同义风险通路合并"
        }
      ],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "急性与长期效果的矛盾",
          "pro_nodes": [
            "n_pro_mech_ursodeoxycholic_acid"
          ],
          "con_nodes": [
            "n_rp",
            "n_adv"
          ],
          "note": "急性改善与长期不良影响可能存在矛盾"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "疗效依赖于是否存在足够的靶器官暴露",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "可能激活的风险链可导致AdversePhenotypeZ",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "药物对特定通路的作用方向是否正确",
      "靶器官的可达性和暴露是否充分"
    ],
    "falsification_tests": [
      "是否有研究表明长期结局的改善?",
      "药代动力学是否支持靶器官的充分暴露?"
    ],
    "next_focus_for_pi": [
      "请求 Proponent 提供其他机制以缓解风险链",
      "对冲突热点进行重点评估"
    ]
  }
}